This list enumerates ICD-10 (International Classification of Diseases) codes for various diseases and health conditions related to congenital anomalies, genetic disorders, and gender abnormalities. Each code represents a specific condition or group of related conditions.
Đối tượng áp dụng
This list is used by healthcare professionals for accurate diagnosis and monitoring of patients with the aforementioned conditions, as well as in research and public health statistics.
Các điểm cốt lõi
- Q03
- Q56
- Q96.0
- Q97.1
- Q98.4
🌐 Tác động xã hội từ văn bản này
- The diseases and health conditions listed may have serious implications for the individual's, social, and occupational life.
- Accurate diagnosis helps improve treatment outcomes and support for patients.
- Statistics on these diseases play an important role in shaping public health policies.
❓ Câu hỏi thường gặp
What does ICD-10 code mean?
The ICD-10 code is an international coding system for health conditions and injuries. It aids in standardizing the recording and reporting of healthcare worldwide.
How can one determine if they or someone else may be affected by a condition listed here?
You should consult a doctor or healthcare specialist if you suspect that you or another person may have any of the conditions listed.
Are there ways to prevent these diseases?
Some diseases can be detected early through genetic testing. However, many are due to genetic factors and prevention is difficult.
Toàn văn
|
MINISTRY OF HEALTH No.: /2026/TT-BYT
|
THE SOCIALIST REPUBLIC OF VIET NAM Independence - Freedom - Happiness Hanoii, date and year 5 202626 |
DECREE
Regulating DETAILItems of Diseases to be Reported and Disclosed for Gender Determination of Fetus to Serve Diagnosis and Treatment Based on the Population Law No. 113/2025/QH15; Based on the Law on Medical Examination, Treatment No. 15/2023/QH15;Based on Decree No. 42/2025/NĐ-CPdated February 27, 2025
of the Government regulating the functions, tasks, powers and organizational structure of the Ministry of Health; In accordance with the proposal by the Director of the Population Department;
The Minister of Health promulgates
D ECREE
Regulating DETAIL Items of Diseases
to be Reported and Disclosed for Gender Determination of Fetus to Serve Diagnosis and Treatment.
Article 1. Detail of Items of Diseases to be Reported and Disclosed for Gender Determination of Fetus to Serve Diagnosis and Treatment The list of diseases to be reported and disclosed for gender determination of fetus to serve diagnosis and treatment is annexed hereto in accordance with the detailed provisions at Clause 3, Article 6 of the Population Law. Article 2. Interpretation of Terms1. Determining the gender of the fetus for diagnosis and treatment purposes refers to using specialized techniques to determine the sex chromosomes, sex-determining genes or sex phenotype of the fetus in order to serve diagnosis of genetic disorders with different manifestations between males and females. 2. Diseases related to gender for diagnosis and treatment are diseases, defects, syndromes, or congenital conditions related to sex chromosomes or genes that affect the process of determining and developing gender, where the determination of fetal gender has significance in diagnosis, prognosis, treatment, or prevention of disease. 3. Genetic Disorders Linked to Gender is a group of diseases caused by genetic variants on sex chromosomes.4. Gender Development Disorder refers to congenital conditions causing atypical development of gender due to abnormalities of sex chromosomes, reproductive glands, or genitalia. Article 3. Principles for Establishing the List of Diseases to be Reported and Disclosed for Gender Determination of Fetus to Serve Diagnosis and Treatment
Diseases to be reported and disclosed for gender determination of fetus to serve diagnosis and treatment must meet the following principles:
1. Directly related to gender with clinical significance for diagnosis, prognosis or prenatal, neonatal decision-making, including: diseases related to gender, genetic disorders linked to gender, abnormalities in number or structure of sex chromosomes, gender development disorders.
2. Have a scientific name in Vietnamese; consistent with the international classification code ICD-10.
Article 4. Enforceability
This Decree takes effect from July 1, 2026.
Article 5. Implementation
1. Population Department:
a) Shall coordinate with relevant units to organize the implementation, guidance, and inspection of this Decree;
b) Every two years or when there are professional, technical, or legal requirements, the Population Department shall lead the review, propose amendments, and supplements to the list specified in this Decree;
c) Shall publish the list of diseases to be reported and disclosed for gender determination of fetus to serve diagnosis and treatment on the Population Department's website and the Ministry of Health's e-Government portal.
2. Departments, Bureaus, Offices under the Ministry of Health shall implement this Decree in accordance with their functions and tasks.
3. Provincial People's Committees' health professional agencies shall direct, guide, and inspect healthcare facilities under their jurisdiction to comply with regulations for determining fetal gender for diagnosis and treatment; handle violations according to authority or refer to competent authorities as required by law.
4. Healthcare Facilities:
a) Shall report and disclose the gender of the fetus for diagnosis and treatment in accordance with the list specified in this Decree;
b) Shall provide counseling before and after performing technical services regarding the scope, significance, limitations of the service, and the inability to detect certain diseases during testing;
c) The head of the healthcare facility shall be responsible under the law if there is a violation of reporting or disclosing fetal gender for purposes other than diagnosis, treatment, or outside the scope specified in this Decree;
d) In cases where genetic disorders related to gender are not detected due to technical limitations, screening methods, lack of risk factors, new variant emergence leading to inability to determine the disease, then no violation of professional regulations.
IN THE COURSE OF IMPLEMENTATION, IF ANY DIFFICULTIES OR OBSTACLES ARISE, ORGANIZATIONS, AND INDIVIDUALS MAY REFLECT TO THE MINISTRY OF HEALTH (Population Department) FOR GUIDANCE AND RESOLUTION./.
RECEIPT:
- Central Committee of the Communist Party of Vietnam;
- Prime Minister, Deputy Prime Ministers of the Government;
- Ministries and agencies at the same level as ministries, agencies under the Government;
- People's Councils, People's Committees of provinces and municipalities directly under the Central Government;
- Central Party Office and its Departments;
- Office of the General Secretary;
- Office of the President;- Ethnic Affairs Committee and other Committees of the National Assembly; - Office of the National Assembly;- Supreme People's Court;
|
- Supreme People's Procuratorate; - Auditor General's Office; - Social Policy Bank; - Vietnam Investment Bank; - Central Committee of the Vietnamese Fatherland Front; - Central Offices of Political-Social Organizations; - Minister of Health (for reporting); - Deputy Ministers of Health (for coordination and guidance); - Provincial Departments of Health in provinces and municipalities directly under the Central Government; - Office of the Prime Minister: Gazette; e-Government Portal of the Government; - Departments, Bureaus, Offices under the Ministry of Health - Ministry of Health; - e-Government Portal of the Ministry of Health; - Population Department in provinces and municipalities directly under the Central Government; - VT, CDS, PC. KT. MINISTER DEPUTY MINISTERS Pham Xuan Tuyen MINISTRY OF HEALTH THE SOCIALIST REPUBLIC OF VIET NAM Independence - Freedom - Happiness DETAIL LIST OF DISEASES TO BE REPORTED AND DISCLOSED FOR GENDER DETERMINATION OF FETUS TO SERVE DIAGNOSIS AND TREATMENT (Annexed to Decree No. /TT-BYT |
of the Minister of Health dated May 2026) STT ICD-10 Code
Name/Condition
|
|
Disease/Syndrome
|
H35.5 Hereditary Retinal Dystrophy |
H90Sensorineural Hearing Loss and/or Conductive Hearing Loss H90.3
Bilateral Sensorineural Hearing Loss
Q55.8Annexed to Circular No. 03/TT-BYT of the Minister of Health dated May month, 2026STT /2026ICD-10 Code Name Disease/Syndrome H35.5)
|
Retinal Dystrophy |
H90 |
Conductive and/or Sensorineural Hearing Loss H90.3 |
|
1 |
Bilateral Sensorineural Hearing Loss |
Q55.8 |
|
2 |
Q99.9 |
Chromosomal Abnormality, Unspecified |
|
3 |
H90.3 |
Hearing impairment of sensory organs, both ears |
|
4 |
Q55.8 |
Congenital anomaly of male genital organs other than those specified |
|
5 |
D55.0 |
Hemolytic anemia due to glucose-6-phosphate dehydrogenase (G6PD) deficiency |
|
6 |
D58.1 |
Inherited elliptocytosis [oval] |
|
7 |
D58 |
Other inherited hemolytic anemia |
|
8 |
D61.3 |
Aplastic anemia of unknown origin |
|
9 |
D64 |
Other anemias |
|
10 |
D64.0 |
Hereditary sideroblastic anemia |
|
11 |
D66 |
Inherited factor VIII deficiency |
|
12 |
D67 |
Inherited factor IX deficiency |
|
13 |
D68.5 |
Primary thrombocytosis |
|
14 |
D69.4 |
Other primary thrombocytopenias |
|
15 |
D80.5 |
Combined immunodeficiency with low or normal B cell count and increased IgM |
|
16 |
D81.2 |
Severe combined immunodeficiency (SCID) with low or normal B cell count |
|
17 |
D81.8 |
Other severe combined immunodeficiencies |
|
18 |
D81.9 |
Mixed immunodeficiency, unspecified |
|
19 |
D82.0 |
Wiskott-Aldrich syndrome |
|
20 |
D84.1 |
Complement system abnormalities |
|
21 |
D84.9 |
Immunodeficiency, unspecified |
|
22 |
D89.8 |
Other disorders of immune mechanism, not classified elsewhere |
|
23 |
E03 |
Other hypothyroidism |
|
24 |
E20.8 |
Other subclinical hypothyroidism |
|
25 |
E22.2 |
Syndrome of inappropriate antidiuretic hormone secretion (SIADH) |
|
26 |
E23.0 |
Pituitary insufficiency |
|
27 |
E25 |
Adrenal-gonadal disorders |
|
28 |
E26.8 |
Other hyperaldosteronism |
|
29 |
E28.3 |
Primary ovarian failure |
|
30 |
E30.1 |
Precocious puberty |
|
31 |
E34.5 |
Androgen resistance syndrome |
|
32 |
E70.3 |
Albinism |
|
33 |
E72.0 |
Other amino acid transport disorders |
|
34 |
E72.4 |
Ornithine metabolism disorder |
|
35 |
E74.0 |
Glycogen storage disease |
|
36 |
E74.4 |
Pyruvate and/or glucose metabolism disorder |
|
37 |
E75.2 |
Other sphingolipidoses |
|
38 |
E76.1 |
Mucopolysaccharidosis type II |
|
39 |
E77.8 |
Other glycoprotein metabolism disorders |
|
40 |
E79.1 |
Lesch-Nyhan syndrome |
|
41 |
E79.8 |
Other purine and/or pyrimidine metabolism disorders |
|
42 |
E80.0 |
Inherited erythropoietic porphyria |
|
43 |
E83.3 |
Phosphorylase and/or phosphatase metabolism disorder |
|
44 |
F78 |
Other intellectual developmental disorders |
|
45 |
F79 |
Intellectual developmental disorder, unspecified |
|
46 |
F84.2 |
Rett syndrome |
|
47 |
G11.4 |
Hereditary spastic paraplegia |
|
48 |
G12.1 |
Other hereditary spinal muscular atrophies |
|
49 |
G40 |
Epilepsy |
|
50 |
G60.0 |
Inherited sensory and/or motor neuropathies |
|
51 |
G71.0 |
Myotonic dystrophy |
|
52 |
G71.2 |
Congenital myopathies |
|
53 |
H26.0 |
Juvenile cataract, in children and/or young adults and/or presbyopia |
|
54 |
H31.2 |
Hereditary retinal dystrophy |
|
55 |
H33.1 |
Retinal detachment and/or retinoschisis |
|
56 |
H53.5 |
Color vision disorders |
|
57 |
H53.6 |
Night blindness |
|
58 |
H55 |
Ocular oscillations and/or other ocular motility disorders |
|
59 |
H90 |
Conductive hearing loss and/or sensorineural hearing loss |
|
60 |
H90.5 |
Sensorineural hearing loss, unspecified |
|
61 |
I42.0 |
Dilated cardiomyopathy |
|
62 |
K00 |
Dental and/or tooth eruption disorders |
|
63 |
K00.5 |
Other hereditary dental structure abnormalities, not classified elsewhere |
|
64 |
K59.8 |
Other specified functional gastrointestinal disorders |
|
65 |
L67.8 |
Other hair and/or hair fiber abnormalities |
|
66 |
L85.8 |
Other determined thickening of the epidermis |
|
67 |
L85.9 |
Thickening of the epidermis, unspecified |
|
68 |
L99* |
Other skin and/or subcutaneous tissue abnormalities due to conditions classified elsewhere |
|
69 |
L99.0* |
Scleroderma-like dermatosis (E85.-†) |
|
70 |
N04 |
Renal tubular acidosis |
|
71 |
N20.0 |
Urolithiasis |
|
72 |
N25.1 |
Diabetes insipidus |
|
73 |
N25.8 |
Other disorders due to renal tubular dysfunction |
|
74 |
N25.9 |
Renal tubular dysfunction, unspecified |
|
75 |
N46 |
Male infertility |
|
76 |
Q03 |
Congenital hydrocephalus |
|
77 |
Q04.3 |
Other congenital brain anomalies |
|
78 |
Q04.8 |
Other specified congenital brain malformations |
|
79 |
Q10.3 |
Other congenital eyelid abnormalities |
|
80 |
Q11.2 |
Microphthalmia |
|
81 |
Q24.9 |
Congenital heart defects, unspecified |
|
82 |
Q34.8 |
Other specified congenital respiratory malformations |
|
83 |
Q41.8 |
Other specified congenital malformations of the small intestine |
|
84 |
Q50 |
Congenital anomalies of the ovaries, fallopian tubes and/or broad ligament |
|
85 |
Q50.3 |
Other specified congenital ovarian malformations |
|
86 |
Q51 |
Congenital uterine and/or cervical malformations |
|
87 |
Q54 |
Low posterior urethral meatus |
|
88 |
Q54.9 |
Low posterior urethral meatus, unspecified |
|
89 |
Q55 |
Other specified congenital malformations of the male genital organs |
|
90 |
Q56 |
Gender identity not fully determined and/or pseudohermaphroditism |
|
91 |
Q77.3 |
Multiple epiphyseal dysplasia |
|
92 |
Q77.7 |
Spondyloepiphyseal dysplasia |
|
93 |
Q78.0 |
Osteogenesis imperfecta |
|
94 |
Q78.5 |
Metaphyseal dysplasia |
|
95 |
Q80.1 |
X-linked ichthyosis |
|
96 |
Q82.3 |
Incontinentia pigmenti |
|
97 |
Q82.4 |
Ectodermal dysplasia (hypohidrotic) |
|
98 |
Q82.8 |
Other specified congenital malformations of the skin |
|
99 |
Q87 |
Congenital anomalies affecting multiple systems, unspecified |
|
100 |
Q87.0 |
Congenital anomaly affecting mainly facial appearance [shape]Q87.1Congenital anomaly affecting mainly stature |
|
101 |
Q87.2 |
Congenital anomaly affecting mainly the limbs |
|
102 |
Q87.3 |
Congenital anomaly with excessive early growth |
|
103 |
Q87.8 |
Other specified congenital anomalies, not classified elsewhere |
|
104 |
Q89.3 |
Dextrocardia |
|
105 |
Q93.5 |
Other chromosomal deletions |
|
106 |
Q96 |
Turner syndrome |
|
107 |
Q96.0 |
Karyotype 45,X |
|
108 |
Q96.1 |
Karyotype 46,X iso (Xq) |
|
109 |
Q96.2 |
Karyotype 46,X with abnormal sex chromosome, except iso (Xq) |
|
110 |
Q96.3 |
Mosaic, 45,X/46,XX or XY |
|
111 |
Q96.4 |
Mosaic, 45,X/different cell line with abnormal sex chromosome |
|
112 |
Q96.8 |
Other mosaic Turner syndrome |
|
113 |
Q96.9 |
Turner syndrome, unspecified |
|
114 |
Q97 |
Other sex chromosomal abnormalities, female phenotype, not classified elsewhere |
|
115 |
Q97.0 |
Karyotype 47,XXX |
|
116 |
Q97.1 |
Female with more than three X chromosomes |
|
117 |
Q97.2 |
Mosaic, different cell line with varying number of X chromosomes |
|
118 |
Q97.3 |
Female with 46,XY karyotype |
|
119 |
Q97.8 |
Other sex chromosomal abnormalities, female phenotype |
|
120 |
Q97.9 |
Sex chromosomal abnormalities, female phenotype, unspecified |
|
121 |
Q98 |
Other sex chromosomal abnormalities, male phenotype, not classified elsewhere |
|
122 |
Q98.0 |
Klinefelter syndrome with 47,XXY karyotype |
|
123 |
Q98.1 |
Klinefelter syndrome in males with more than two X chromosomes |
|
124 |
Q98.2 |
Klinefelter syndrome in males with 46,XX karyotype |
|
125 |
Q98.3 |
Other males with 46,XX karyotype |
|
126 |
Q98.4 |
Klinefelter syndrome, unspecified |
|
127 |
Q98.5 |
Karyotype 47,XYY |
|
128 |
Q98.6 |
Male with abnormal sex chromosome structure |
|
129 |
Q98.7 |
Male with mosaicism of sex chromosomes |
|
130 |
Q98.8 |
Other sex chromosomal abnormalities, male phenotype |
|
131 |
Q98.9 |
Sex chromosomal abnormalities, male phenotype, unspecified |
|
132 |
Q99.0 |
Mosaic 46,XX/46,XY |
|
133 |
Q99.1 |
True hermaphroditism 46,XX |
|
134 |
Q99.2 |
Fragile X chromosome |
|
135 |
Q99.8 |
Other chromosomal abnormalities |
|
136 |
Q99.9 |
Chromosomal abnormalities, unspecified |
|
137 |
Q99.9 |
Abnormality of chromosomes, unspecified |
Văn bản gốc (PDF)
Bản đồ quan hệ
Bấm vào một văn bản để mở. Viền đỏ = quan hệ làm thay đổi hiệu lực.
Bản dịch
Văn bản này có sẵn ở các ngôn ngữ sau: